Company intelligence / Profile preview
Circadian Therapeutics
Oxford, England, United Kingdomcircadiantherapeutics.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Preclinical
01
Overview
Circadian Therapeutics develops therapeutics targeting diseases caused by disruption of circadian rhythms. Founded as an Oxford University spin-out in 2016, it leverages molecular understanding of the body clock to address root causes rather than symptoms. Its portfolio includes small molecule drugs for sleep/circadian rhythm disorders, metabolic diseases like obesity, neurodegeneration such as Alzheimer’s disease, and other conditions linked to body clock dysfunction. Most programs are preclinical or discovery-stage.
- Therapeutic areas
- OphthalmologyCardiovascularNeurologyMetabolic Disorders
- Modalities
- Small molecules (primary)Unknown/other (some programs not fully disclosed)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
No major pharma partnerships publicly listed for this entity; note that a similarly-named Australian company ("Circadian Technologies Limited") had historic deals with ImClone/Eli Lilly but this appears unrelated to the UK-based Circadian Therapeutics Limited described here.
Beyond the preview
Go deeper on Circadian Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Circadian Therapeutics.